Abstract OBJECTIVE: Thymic stromal lymphopoietin (TSLP) plays an important role in initiating dendritic cell mediated allergic inflammation. This study was designed to examine the effects of inhaled budesonide on TSLP expression in the lung tissues and on the bronchial-pulmonary pathology in asthmatic rats. METHODS: Thirty-two female Sprague-Dawley rats were sensitized and challenged with inhaled ovabumin (OVA) to induce asthma. The asthmatic rats were randomly divided into 2 groups on the 22nd day of OVA challenge: a budesonide treatment group that received inhaled budesonide at 0.32 mg/kg daily for 7 days and an asthma control group that received inhaled 0.9% normal saline for 7 days. TSLP expression in the lung tissues was measured by Western blot and fluorescent-immunohistochemistry 29 and 36 days after OVA challenge. Bronchial-pulmonary pathological changes were evaluated by hematoxylin & eosin and periodic acid-schiff staining. RESULTS: Budesonide treatment alleviated airway inflammation when compared with the asthma control group 29 days after OVA challenge. However, the airway inflammatory reactions were aggravated in the budesonide treatment group 36 days after OVA challenge (7 days after budesonide discontinuance). TSLP expression in the lung tissues was significantly lower in the budesonide treatment group than that in the asthma control group both 29 and 36 days after OVA challenge (P<0.05). CONCLUSIONS: Inhaled budesonide can inhibit the TSLP expression in the lung tissues and alleviate lung inflammatory reactions in asthmatic rats, but there is end-of-dose failure.［Chin J Contemp Pediatr, 2010, 12 (10):816-819］
LIU Hui,PAN Jia-Hua,LOU Wan-Ling et al. Effects of inhaled budesonide on the bronchial-pulmonary pathology and expression of thymic stromal lymphopoietin in lung tissues in asthmatic rats[J]. 中国当代儿科杂志, 2010, 12(10): 816-819.
LIU Hui,PAN Jia-Hua,LOU Wan-Ling et al. Effects of inhaled budesonide on the bronchial-pulmonary pathology and expression of thymic stromal lymphopoietin in lung tissues in asthmatic rats[J]. CJCP, 2010, 12(10): 816-819.
［4］Mauad T, Silva LF, Santos MA, Grinberg L, Bernardi FD, Martins MA, et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma［J］.Am J Respir Crit Care Med, 2004, 170 (8): 857-862.
［5］Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial［J］. Am J Respir Crit Care Med, 2001, 163(1): 32-36.
［6］Wempe JB, Tammeling EP, Koeter GH, Hakansson L, Venge P, Postma DS. Blood eosinophil numbers and activity during 24 hours:effects of treatment with budesonide and bambuterol［J］. J Allergy Clin Immunol, 1992, 90 (5)：757-765.
［9］Lee HC, Ziegler SF．Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB［J］. Proc Natl Acad Sci U S A, 2007，104(3)：914-919.
［10］Cato AC, Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids［J］. Bioessays, 1996, 18(5): 371-378.
